Eculizumab in severe Shiga-toxin-associated HUS
- PMID: 21612462
- DOI: 10.1056/NEJMc1100859
Eculizumab in severe Shiga-toxin-associated HUS
Similar articles
-
Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.Pediatr Blood Cancer. 2019 Nov;66(11):e27913. doi: 10.1002/pbc.27913. Epub 2019 Jul 9. Pediatr Blood Cancer. 2019. PMID: 31286658
-
Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study.Nephrol Dial Transplant. 2020 Dec 4;35(12):2147-2153. doi: 10.1093/ndt/gfz158. Nephrol Dial Transplant. 2020. PMID: 31411695
-
Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab.Pediatr Nephrol. 2018 Dec;33(12):2371-2381. doi: 10.1007/s00467-018-4033-0. Epub 2018 Aug 29. Pediatr Nephrol. 2018. PMID: 30159625
-
[Escherichia coli associated hemolytic and uremic syndrome: what lessons can be learned after the European epidemic of 2011?].Nephrol Ther. 2013 Jun;9(3):129-36. doi: 10.1016/j.nephro.2012.10.011. Epub 2012 Dec 21. Nephrol Ther. 2013. PMID: 23266201 Review. French.
-
Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.Nephrol Dial Transplant. 2012 Oct;27(10):3807-15. doi: 10.1093/ndt/gfs394. Nephrol Dial Transplant. 2012. PMID: 23114903
Cited by
-
Atypical hemolytic uremic syndrome: a clinical conundrum.Pediatr Nephrol. 2016 Oct;31(10):1615-24. doi: 10.1007/s00467-016-3369-6. Epub 2016 May 2. Pediatr Nephrol. 2016. PMID: 27139899
-
Kidney diseases caused by complement dysregulation: acquired, inherited, and still more to come.Clin Dev Immunol. 2012;2012:695131. doi: 10.1155/2012/695131. Epub 2012 Nov 14. Clin Dev Immunol. 2012. PMID: 23227086 Free PMC article. Review.
-
Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.Toxins (Basel). 2021 Apr 26;13(5):306. doi: 10.3390/toxins13050306. Toxins (Basel). 2021. PMID: 33925836 Free PMC article. Review.
-
Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation.Pediatr Nephrol. 2012 Dec;27(12):2327-31. doi: 10.1007/s00467-012-2283-9. Epub 2012 Aug 19. Pediatr Nephrol. 2012. PMID: 22903728
-
A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement.Pediatr Nephrol. 2019 Mar;34(3):517-527. doi: 10.1007/s00467-018-4112-2. Epub 2018 Oct 25. Pediatr Nephrol. 2019. PMID: 30362078
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources